JULIA P GREGORY
CIK 1226675 · CEO · last filed 2026-05-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$471.7K
Companies
7
Total Filings
28
Lifetime Open-Market Net
-$2.53M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NRIX | Director | 10,750 | $16.95 | $182.2K | $0 | 7 | 2026-05-15 |
| BHVN | Director | 25,665 | $11.28 | $289.5K | -$2.58M | 13 | 2025-05-07 |
| Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted | Director | — | — | — | $0 | 1 | 2022-10-03 |
| CONTRAFECT Corp (CFRX.W) Delisted | CEO | — | — | — | $0 | 1 | 2016-02-17 |
| CONTRAFECT Corp (CFRX.Z) Delisted | CEO | 50,283 | — | — | $54.3K | 3 | 2015-03-03 |
| LXRX | EVP and CFO | — | $1.92 | — | $0 | 1 | 2008-02-11 |
| LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted | EVP, Corp Dev and CFO | — | — | — | $0 | 1 | 2007-02-15 |
Recent Filings · Page 3 of 3
28 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-03 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2017-08-04 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2016-02-17 | CONTRAFECT Corp (CFRX.W) Delisted | — | — | $0 | EDGAR |
| 2015-03-03 | CONTRAFECT Corp (CFRX.Z) Delisted | Buy (P) | +11,778 | $54.3K | EDGAR |
| 2015-02-10 | CONTRAFECT Corp (CFRX.Z) Delisted | — | — | $0 | EDGAR |
| 2014-10-08 | CONTRAFECT Corp (CFRX.Z) Delisted | Grant (A) | +29,946 | $119.8K | EDGAR |
| 2008-02-11 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2007-02-15 | LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–28 of 28
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.